In this episode of the Oncology Spotlight podcast, we are honored to host Prof. Keith Kerr, a Consultant Pathologist at Aberdeen Royal Infirmary and Honorary Professor at the University of Aberdeen. With over 35 years of experience in thoracic pathology, Prof. Kerr is a globally recognized expert in non-small cell lung cancer (NSCLC), particularly in predictive and diagnostic biomarkers, immunotherapy, and personalized medicine.

Join us as Prof. Kerr shares his remarkable journey from medical school to becoming a leading pathologist specializing in thoracic oncology. In this insightful conversation, he delves into:

• His Path to Pathology: Discover what led Prof. Kerr to specialize in thoracic oncology and how a pivotal research project in lung cancer set the course for his distinguished career.
  

• Understanding Reflex Testing in NSCLC: Prof. Kerr explains the concept of reflex testing, why it’s essential in the timely and accurate diagnosis of lung cancer, and how it has transformed patient care by ensuring that crucial molecular and biomarker tests are conducted without delay.
  

• The Impact of New Treatment Options: Learn how the advent of targeted therapies and immunotherapies for NSCLC has increased the importance of reflex testing and how it’s applied in current clinical practices.
  

• Challenges and Contributions to Lung Cancer Guidelines: Prof. Kerr shares his experiences and challenges in contributing to numerous national and international lung cancer guidelines, offering a unique perspective on the evolving standards in lung cancer diagnosis and treatment.
  

• Future of Pathology and the Role of AI: Prof. Kerr also discusses the future of pathology training, especially with the integration of new technologies and artificial intelligence in diagnostics, particularly for lung cancer.

Whether you're a healthcare professional, a student, or simply interested in the latest advancements in oncology, this episode offers valuable insights into the evolving field of lung cancer diagnosis and treatment.For inquiries, contact us at info@oncoassist.com

Let's connect:

Website: www.oncoassist.com

Twitter: https://twitter.com/oncoassist

LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool

Instagram:https://www.instagram.com/oncoassist/

Facebook: https://www.facebook.com/ONCOassist

Welcome to another episode of the Oncology Spotlight Podcast! In this episode, we're thrilled to have Eoin Tabb, Chief 2 Pharmacist specializing in Clinical Cancer Services at University Hospital Waterford, Ireland, as our guest. Eoin is a passionate advocate for digital health transformation, leading a team dedicated to enhancing the safety and efficiency of cancer care.

In this insightful conversation, Eoin shares his journey to becoming an oncology pharmacist, his specialization in cancer care, and how digital health is revolutionizing oncology today and in the future. We also dive into his work with The Irish Haematology Oncology Podcast, a jargon-free exploration of cancer care, designed to educate healthcare professionals and enthusiasts alike.

Key Discussion Points:

• Eoin’s background and journey to becoming a pharmacist

• Specializing in cancer care and the reasons behind it

• The impact of digital health transformation on cancer care today and its future potential

• The inspiration and goals behind The Irish Haematology Oncology Podcast

• Challenges faced by oncology professionals today

• How digital tools are helping to address these challenges

• The potential opportunities for AI in oncology

• Eoin’s aspirations for advancing cancer care through his current role and broader initiatives

Whether you’re a healthcare professional, digital health enthusiast, or simply interested in the future of cancer care, this episode offers valuable insights.

👉 Don’t forget to like, comment, and subscribe to our channel for more insightful episodes!🔔 Turn on notifications so you never miss an update.

🔗 Links:

• Listen to The Irish Haematology Oncology Podcast:

• Connect with Eoin Tabb on LinkedIn:

• For inquiries, contact us at info@oncoassist.com

Let's connect:

Website: www.oncoassist.com

Twitter: https://twitter.com/oncoassist

LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool

Instagram:https://www.instagram.com/oncoassist/

Facebook: https://www.facebook.com/ONCOassist

Welcome to the Oncology Spotlight! In this episode, join us as we delve into the forefront of cancer care with Professor Gerry Hanna, a distinguished radiation oncologist and Marie Curie Chair of Clinical Oncology at Trinity College Dublin.

Key Discussion Points:

Introduction: Get to know Professor Gerry Hanna and his illustrious career spanning leading institutions like Queen’s University Belfast and the University of Melbourne.

Latest Developments in Lung Cancer Treatment: Professor Hanna shares groundbreaking advancements shaping the future of lung cancer care.

Evolution of CRT in Lung Cancer: Discover insights into how Combined Radiation Therapy (CRT) has progressed over the past five years.

Interpreting Scans Post-CRT: Learn about challenges and strategies in interpreting scans, especially in conjunction with immunotherapy.

Emerging Guidelines for Scan Interpretation: Professor Hanna outlines emerging best practices crucial for accurate treatment decisions.

Role of Multidisciplinary Teams (MDT): Understand the pivotal role MDTs play in enhancing diagnostic accuracy and treatment planning.

Current Research Initiatives: Explore ongoing research projects like PERTAIN and CONCORDE and their potential impact on cancer care.

Challenges in Oncology Today: Professor Hanna discusses the significant challenges facing oncology and strategies to overcome them.

Future Prospects with AI: Gain insights into the promising intersection of oncology and artificial intelligence (AI).

Don't miss this enlightening conversation that promises to deepen your understanding of cutting-edge oncology practices and future directions in cancer treatment.

🎧 Listen to the full podcast episode: LINK and join the conversation!